Autopsy report · NCT04890093
Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors
Cause of deathOther
“Pending updated agreements in order to enroll additional participants.”
Life of this trial
- Registered 3 years 6 months before it started.
- Suspended: paused, and may or may not restart.
- 64 participants planned (an estimate, not an actual count).
Vital statistics
- Status
- Suspended
- Phase
- Phase 1, Phase 2
- Sponsor
- National Cancer Institute (NCI)
- Sponsor type
- US National Institutes of Health
- Conditions
- Sarcoma, Ewing; Rhabdomyosarcoma
- Interventions
- PEN-866; Vincristine; Temozolomide
- Participants
- 64 (planned, not actual)
- Sites
- 2
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.